BIT's 2nd Annual World Cancer Congress 2009 is an interactive conference providing practicing oncologists with the latest research on epidemiologic, cancer molecular mechanisms, drug discovery, therapeutics development, diagnosis, clinical data, and best practices. The conference consists of Six Tracks and two Workshops that address current issues in cancer area from basic research to clinical therapy. The conference also focuses on the recent technologies that are directly applicable to the practice of cancer research and therapeutic discovery and development. The conference will be very beneficial for the participants, providing them a face-to-face platform to exchange ideas, views and updates related to this area. The conference offers a wonderful opportunity to hear talks from renowned overseas speakers. This time the conference expects the participation of more than 450 cancer specialists from a wide range of disciplines. The presentations made by them will provide information on the latest developments in basic science and clinical treatment. The event, no doubt, will be a platform to establish and create network with senior scientists, executives and others over 42 Scientific and Business Sessions as well as get the detailed information about the research discoveries.
BIT Life Sciences, Inc.